Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

CD21 Antikörper (FITC)

CR2 Reaktivität: Schwein FACS, IHC, IP Wirt: Maus Monoclonal 5K109 FITC

Produktnummer ABIN2224129

Datenblatt (PDF)

Target Alle CD21 (CR2) Antikörper anzeigen

CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
Reaktivität
136

27

27

20

19

10

9

9

3

3

3

2

1

1

1

1

1

1
Schwein
Wirt
102

65

11
Maus
Passende Sekundärantikörper
Klonalität
119

58

1
Monoklonal
Konjugat
70

24

19

15

8

4

3

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser CD21 Antikörper ist konjugiert mit FITC
Applikation
124

55

54

37

29

28

26

14

12

6

6

6

5

4

3

1

1

1

1
Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP)

Kreuzreaktivität

Schwein

Kreuzreaktivität (Details)

Calculated cross reactivity: Po

Produktmerkmale

CD21 (CR2, C3d Receptor, EBV Receptor) (FITC)

Aufreinigung

Purified.

Immunogen

Porcine CD21.

Klon

5K109

Isotyp

IgG1 kappa

Top Product

Discover our top product CR2 Primärantikörper
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibody
CR2 Reaktivität: Human FACS, IHC, WB, ELISA, IF, StM, Coat Wirt: Maus Monoclonal CR2-2754 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 Reaktivität: Human FACS, IHC, WB, ELISA, IF Wirt: Kaninchen Monoclonal 16F10 unconjugated Recombinant Antibody

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 740-964) antibody
CR2 Reaktivität: Human FACS, ELISA Wirt: Maus Monoclonal 2D2H6 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 300-590) antibody
CR2 Reaktivität: Human IHC, WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 Reaktivität: Human, Schwein, Rind (Kuh), Hund FACS, IHC (fro) Wirt: Maus Monoclonal LT21 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 981-1092) antibody
CR2 Reaktivität: Human, Ratte FACS, WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 44-196) antibody
CR2 Reaktivität: Human IHC, ELISA, StM, Coat Wirt: Maus Monoclonal CR2-1952 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibody
CR2 Reaktivität: Human FACS, IHC, WB, IF, StM Wirt: Kaninchen Monoclonal CR2-3124R unconjugated Recombinant Antibody

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody (FITC)
CR2 Reaktivität: Human, Schwein, Rind (Kuh), Hund FACS Wirt: Maus Monoclonal LT21 FITC

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Buffer

Supplied as a liquid in PBS, 0.09 % sodium azide, before the additon of glycerol to 40 %.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

4 °C,-20 °C

Informationen zur Lagerung

4°C (-20°C Glycerol)
Target

CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))

Andere Bezeichnung

CD21 (CR2 Produkte)

Pathways

Komplementsystem